Li et al., "Clearance mechanisms of Alzheimer's amyloid-B peptide: implications for therapeutic design and diagnostic tests," Molecular Psychiatry, vol.
In their current work, the researchers at the RIKEN Brain Science Institute focused on AB43, an amyloid-B peptide found just as often in patient brains as AB42, but about which relatively little is known.